Rheumatoid Arthritis News

    Skip to content
    • Home
    • Treatments
      • Tofacitinib (Xeljanz)
    • Experimental Treatments
      • Piclidenoson
      • Kevzara (Sarilumab)
      • Baricitinib (Olumiant)
    • About Us
    • Contact Us
    •
      June 12, 2017August 24, 2022

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      Diplomat Pharmacy has begun filling prescriptions for Kevzara (sarilumab) for patients with moderate to severe rheumatoid arthritis (RA). The announcement comes after the U.S. Food and Drug ... Read more
    • June 7, 2017June 7, 2017

      Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      Active rheumatoid arthritis (RA) patients whose response to methotrexate (MTX) therapy was insufficient showed improvement when MTX was combined with filgotinib, an investigational JAK–1 inhibitor, according ... Read more
    • June 5, 2017June 5, 2017

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      The European Medicines Agency (EMA) has accepted a marketing authorization application from generic pharmaceuticals developer Sandoz for the review of biosimilars for AbbVie’s Humira (adalimumab) and Janssen’s Remicade (infliximab), ... Read more
    • June 2, 2017June 2, 2017

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      Results of a recent study showed that biological therapy regimens, such as Enbrel (etanercept), Humira (adalimumab), ‎Remicade (infliximab), ‎Simponi (golimumab), or ‎Cimzia (certolizumab), are less cost-effective ... Read more
    • May 23, 2017May 23, 2017

      Kevzara Approved by FDA for Treatment of RA in Adults Who Don’t Respond to DMARDs

      Kevzara (sarilumab) was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with moderate to severely active rheumatoid arthritis ... Read more
    Researchers Reveal Key Findings in Genomics Road Map to Disease Origins
    May 2, 2016May 2, 2016

    Researchers Reveal Key Findings in Genomics Road Map to Disease Origins

    News
    Genomics scientists now have more knowledge than ever about the biological and genetic basis of diseases such as rheumatoid arthritis, and to identifying new targeted therapies. Three computational biology teams ... Read more
    Research into Biologic Effects of Combo Treatments for Rheumatoid Arthritis Is Topic of 2 Webinars
    April 29, 2016April 29, 2016

    Research into Biologic Effects of Combo Treatments for Rheumatoid Arthritis Is Topic of 2 Webinars

    News
    Dr. Ernest Choy, FRCP, head of Rheumatology at Cardiff University’s Institute of Infection and Immunity, will lead two webinars examining how the biologic effects of combination treatments can be investigated using an in ... Read more
    Hearing Loss in Rheumatoid Arthritis May Be Aggravated by Alcohol Consumption and Smoking
    April 27, 2016April 27, 2016

    Hearing Loss in Rheumatoid Arthritis May Be Aggravated by Alcohol Consumption and Smoking

    News
    Varying types of hearing loss have been reported in people with rheumatoid arthritis (RA). But while a new study found the auditory system may be involved during the course of RA, the association between ... Read more
    Omega-3 Rich Diet Seen to Have ‘Potent’ Effects in Treating a Mouse Model of Rheumatoid Arthritis
    April 22, 2016April 22, 2016

    Omega-3 Rich Diet Seen to Have ‘Potent’ Effects in Treating a Mouse Model of Rheumatoid Arthritis

    News
    Rheumatoid arthritis (RA) may be effectively treated with the lipid mediator resolvin D1, a metabolite of omega-3 fatty acids, according to a study that found a pronounced easing of the disease in ... Read more
    Immune System Compounds, Alpha Defensins, Seen to Reduce Inflammation Linked to Arthritis
    April 20, 2016April 20, 2016

    Immune System Compounds, Alpha Defensins, Seen to Reduce Inflammation Linked to Arthritis

    News
    Compounds produced by the immune system can help reduce inflammation and prevent damage to healthy tissues, a finding with important implications in the treatment of conditions like rheumatoid arthritis (RA) and sepsis. The study, ... Read more
    B-Cells in Rheumatoid Arthritis Bone Erosion Lead to Identification of Novel Biomarker
    April 18, 2016April 18, 2016

    B-Cells in Rheumatoid Arthritis Bone Erosion Lead to Identification of Novel Biomarker

    News
    University of Rochester Medical Center researchers have studied the joint tissue of rheumatoid arthritis (RA) patients, finding that B-cells in these tissues play an important role in bone erosion, contributing ... Read more
    Smoking Linked to 2x Higher Risk of Premature Death in Rheumatoid Arthritis Patients
    April 15, 2016April 15, 2016

    Smoking Linked to 2x Higher Risk of Premature Death in Rheumatoid Arthritis Patients

    News
    Smoking is associated with earlier death in people with rheumatoid arthritis, a correlation that significantly decreased upon smoking cessation, according to a study led by University of Manchester researchers. The article, “Smoking-related mortality in patients ... Read more
    High-fat Diets Tied to Diseases Like Rheumatoid Arthritis Through Disruption of Cells’ Circadian Rhythm
    April 12, 2016April 13, 2016

    High-fat Diets Tied to Diseases Like Rheumatoid Arthritis Through Disruption of Cells’ Circadian Rhythm

    News
    The consumption of saturated fats — and when in the day they are eaten — dysregulate the circadian rhythm of cells, essentially “jet-lagging” them, and promote chronic low-grade inflammation and metabolic diseases ... Read more
    Phase 3 Trial Shows Rheumatoid Arthritis Symptoms Significantly Improved with Baricitinib
    April 11, 2016April 11, 2016

    Phase 3 Trial Shows Rheumatoid Arthritis Symptoms Significantly Improved with Baricitinib

    News
    Eli Lilly and Incyte Corporation recently announced novel data from the pivotal Phase 3 RA-BEACON global trial of baricitinib, a once-daily oral drug presently under regulatory review for moderate-to-severe rheumatoid arthritis (RA). ... Read more
    FDA Approves Inflectra for Patients with Rheumatoid Arthritis, Other Conditions
    April 8, 2016April 8, 2016

    FDA Approves Inflectra for Patients with Rheumatoid Arthritis, Other Conditions

    News
    Celltrion announced that Inflectra (biosimilar infliximab) has been approved by the U.S. Food and Drug Administration (FDA) for all the same indications that Remicade (infliximab) is approved, including rheumatoid arthritis ... Read more

    Posts navigation

    Older posts
    Newer posts

    Never miss another RA update.

    * indicates required
    Bionews, Inc.
    3 W Garden St
Suite 700
Pensacola, FL 32502
Email: [email protected]
Phone: +1-800-936-1363

    Recent Posts

    • Diplomat selling Kevzara

      Diplomat Pharmacy Begins Dispensing Kevzara to Treat Rheumatoid Arthritis

      June 12, 2017

    • Filgotinib Improves RA Patient Outcomes When Methotrexate Is Inadequate, Study Suggests

      June 7, 2017

    • Truxima, a biosimilar of rituximab

      EMA Accepts Humira and Remicade Biosimilars for Regulatory Review

      June 5, 2017

    • triple therapy

      DMARDs Triple Therapy Provides Better Cost-Effective First Line Strategy for RA, Study Finds

      June 2, 2017

    • About Us
    • Contact Us
    • Terms of Service
    • Privacy Policy

    Disclaimer:

    Rheumatoid Arthritis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
    Copyright © 2013-2025 All rights reserved.